Which has grown faster, CODX or FEMY?

Over the past five years, FEMY grew revenue faster — CODX at a -62.43% CAGR versus FEMY at 12.97%.

How have CODX and FEMY total returns compared?

Over the past 5 years, CODX delivered -66.53% and FEMY delivered -57.27% annualized total return. Past performance doesn't predict future results.

Co-Diagnostics, Inc. (CODX) vs Femasys Inc. (FEMY)

A side-by-side comparison of Co-Diagnostics, Inc. and Femasys Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CODX

Co-Diagnostics, Inc.

$7M

$1.10HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

FEMY

Femasys Inc.

$6M

$2.02HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — CODX vs FEMY

growth of $100 · dividends reinvested · last 5y

CODX -99.5% (-66.0%/yr)FEMY -99.2% (-61.5%/yr)FEMY compounded faster over this window

CODX FEMY

CODX vs FEMY: by the numbers

•CODX is the larger company ($7M vs $6M market cap).
•Both run net losses; FEMY's is the smaller (-534.27% vs -6523.04% net margin).
•FEMY grew revenue faster over the past five years (12.97% vs -62.43% CAGR).

Metrics side by side

Valuation

Metric	CODX	FEMY
P/S ratio	9.53	2.65
P/B ratio	0.54	1.51

Profitability

Metric	CODX	FEMY
Gross margin	64.28%	61.96%
Operating margin	-5025.53%	-763.90%
Net margin	-6523.04%	-534.27%
ROE	-370.16%	-304.78%
ROIC	-219.15%	-209.05%

Growth (annualized)

Metric	CODX	FEMY
Revenue CAGR (5Y)	-62.43%	12.97%
Total return CAGR (5Y)	-66.53%	-57.27%

Frequently asked

Which has grown faster, CODX or FEMY?: Over the past five years, FEMY grew revenue faster — CODX at a -62.43% CAGR versus FEMY at 12.97%.
How have CODX and FEMY total returns compared?: Over the past 5 years, CODX delivered -66.53% and FEMY delivered -57.27% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CODX analysis Full FEMY analysis Interactive comparison tool

Dig into the metrics

Co-Diagnostics ROE Femasys ROE Co-Diagnostics operating margin Femasys operating margin Co-Diagnostics revenue growth Femasys revenue growth Co-Diagnostics free cash flow Femasys free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.